Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

NCT02768389 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT02768389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02768389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
September 6, 2016
Completion date
November 30, 2018
Enrollment
18 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, glioblastoma